Back to the main directory
company_researchgreater_china / Equity
- AAC Technologies - 4Q19: Soft results; pinning high hopes on optics in 2020; upgrade to HOLD. by UOB
- Kingsoft Corp - 4Q19: Top-line beats estimate; margins improve but bottom line dragged by associate loss. Upgrade to BUY by UOB
- Lonking Holdings (3339 HK) - 2019: Posts a slight miss but still a good dividend yield play. BUY by UOB
- Greater China Daily: Friday, March 27, 2020 by UOB
- Haidilao International - 2019: Earnings miss forecast; pressure on table turnover rates and margins by UOB
- Greater China Daily: Monday, March 30, 2020 by UOB
- Brilliance Auto - 2019: Net profit grows 16% yoy, in line with expectations. by UOB
- China Shenhua Energy - 2019: Higher dividends for 2019-21; upgrade to BUY. by UOB
- Chongqing Rural and Commercial Bank - 2019: Growth in line but asset quality remains under pressure. by UOB
- Comba Telecom - Riding on 5G investment boom by UOB
- CMGE Technology Group - 2019: Earnings above estimates; rich gaming pipeline and rosy outlook in 2020. by UOB
- Industrial and Commercial Bank of China - 2019: In line; improvement in asset quality should outweigh NIM compression. by UOB
- Weichai Power - 2019: Net profit up 5% yoy, slightly lower than estimates; cut target price to HK$16.50. by UOB
- Yangtze Optical Fibre And Cable - 2019: Results miss expectations; not out of the woods yet. by UOB
- Shandong Weigao Group Medical - 2019: Results slightly higher than expected; negatively impacted by COVID-19 outbreak. by UOB
- Nexteer - 2019: Results miss estimates; 2020 earnings clouded by COVID-19 in North America and Europe. Slash target price from HK$7.50 to HK$3.80. Entry price: HK$3.00. by UOB
- China Meidong Auto Holdings - 2019: Net profit surged 52% yoy, beating estimates. Raise target price to HK$10.80. Entry price: HK$9.00. by UOB
- China Longyuan Power - 2019: Good cost control to drive earnings; COVID-19 pandemic to have limited impact. by UOB
- Greater China Daily: Wednesday, April 1, 2020 by UOB
- YiChang HEC ChangJiang Pharmaceutical - 2019: Solid results; management sees mixed impact from COVID-19. by UOB
- China Traditional Chinese Medicine Holdings - 2019: Results in line; expect stronger earnings growth ahead. by UOB
- Dongfeng Motor - 2019: Net profit down 0.9% yoy, missing our estimate due to provision for DF PSA. Cut target price to HK$7.00. by UOB
- Inspur International - 2019: Misses expectation due to sharp fall in non-core income; cloud momentum remains strong by UOB
- The United Labs - 2019: Stable results. Management foresees insulin high growth continuing into 2020 by UOB
- Sany Heavy Equipment Int'l - 2019: Improvements on all fronts by UOB